We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ENZ market cap is 59.69M. The company's latest EPS is USD 0.3943 and P/E is 2.89.
Quarter End | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 16.11M | -19.66M | 7.81M | 8.55M | 8.02M |
Operating Income | -15.65M | 13.8M | -5.48M | -2.18M | -2.05M |
Net Income | -15.19M | 57.43M | -6.62M | -3.06M | -3.02M |
Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 110.1M | 76.02M | 117.73M | 107.07M | 31.06M |
Operating Income | 1.73M | -30.37M | 692k | -15.01M | -24.74M |
Net Income | 2.49M | -28.52M | 7.88M | -18.26M | 20.29M |
Quarter End | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 72.06M | 121.88M | 106.31M | 99.08M | 93.47M |
Total Liabilities | 53.13M | 43.42M | 32.03M | 28.3M | 24.44M |
Total Equity | 18.93M | 78.46M | 74.28M | 70.78M | 69.03M |
Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 106.64M | 112.54M | 113.69M | 95.86M | 121.88M |
Total Liabilities | 20.61M | 54.16M | 45.11M | 41.4M | 43.42M |
Total Equity | 86.03M | 58.38M | 68.59M | 54.46M | 78.46M |
Quarter End | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -19.95M | -36.98M | -13.37M | -22.31M | -25.17M |
Investing | -2.19M | 98.98M | -254k | -279k | -422k |
Financing | 3.12M | -1.13M | -518k | -540k | -584k |
Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 4.81M | -17.18M | 387k | -16.59M | -36.98M |
Investing | -8.13M | -2.17M | -34.5M | 25.22M | 98.98M |
Financing | 4.19M | 7M | -242k | -241k | -1.13M |
Market Cap | 59.69M |
Price to Earnings Ratio | 2.89 |
Price to Sales Ratio | 1.89 |
Price to Cash Ratio | 0.71 |
Price to Book Ratio | 0.75 |
Dividend Yield | - |
Shares Outstanding | 51.46M |
Average Volume (1 week) | 43.4k |
Average Volume (1 Month) | 39.08k |
52 Week Change | -15.33% |
52 Week High | 1.50 |
52 Week Low | 0.9901 |
Spread (Intraday) | 0.07 (5.93%) |
Company Name | Enzo Biochem Inc |
Address |
81 executive blvd. ste 3 farmingdale, new york 11735 |
Website | https://www.enzo.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions